Wednesday, December 13, 2023 11:50:54 AM
Linde On Track for Largest Percent Decrease Since July 2022 -- Data Talk
Source: Dow Jones News
Linde plc (LIN) is currently at $408.44, down $18.28 or 4.28%
--On pace for largest percent decrease since July 5, 2022, when it fell 5.19%
--Snaps a three day winning streak
--Down 1.29% month-to-date
--Up 25.22% year-to-date; on pace for best year since 2021, when it rose 31.47%
--Down 4.28% from its all-time closing high of $426.72 on Dec. 12, 2023
--Up 19.42% from 52 weeks ago (Dec. 14, 2022), when it closed at $342.01
--Down 4.28% from its 52-week closing high of $426.72 on Dec. 12, 2023
--Up 33.7% from its 52-week closing low of $305.49 on Jan. 5, 2023
--Traded as low as $404.66
--Down 5.17% at today's intraday low; largest intraday percent decrease since March 15, 2023, when it fell as much as 5.35%
--Fourth worst performer in the S&P 500 today
All data as of 10:19:52 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 13, 2023 10:37 ET (15:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Recent LIN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/02/2024 02:16:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2024 10:37:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2024 05:18:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2024 07:10:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2024 07:00:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2024 06:56:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:55:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:33:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:32:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/14/2024 01:28:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:36:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:25:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:21:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2024 06:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2024 02:10:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:59:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:57:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:46:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:41:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:40:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:35:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 08:33:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 07:12:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:56:23 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM